Diabetes mellitus and noninvasive imaging of atherosclerosis.
With the aging of the baby-boom generation, non-insulin-requiring diabetes mellitus (type 2) has become a worldwide pandemic. The causes of the disease are complex and multifactorial and include genetic disposition, lifestyle choices, abnormal aging processes, and alterations in metabolic processes. The impetus for diagnosing the preclinical effects of diabetes generally has been the individual patient's risk for cardiovascular diseases, heart attack, stroke, and peripheral vascular diseases. This review highlights the newer noninvasive imaging methods designed to provide the early prevention of preclinical atherosclerosis.